HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Childhood thyroid cancer in Belarus, Russia, and Ukraine after Chernobyl and at present.

Abstract
Thyroid cancer in children is usually rare, but in the individuals exposed to radiation risk of disease increases considerably. After the Chernobyl accident in 1986, an over 10-fold maximal elevation in the incidence of thyroid cancer was registered about a decade later, cumulatively resulting in more than a thousand of newly diagnosed cases in children who lived in the territories of Belarus, Russia, and Ukraine affected by radioactive fallouts. Experience from the epidemic substantially promoted knowledge in clinical pediatric oncology, pathology and basic sciences. This article overviews epidemiology, clinical features, results of treatment and follow-up of childhood patients with radiation-induced Chernobyl thyroid cancer in comparison to sporadic cases diagnosed at present. In addition, we discuss general issues of pathology and molecular findings in childhood thyroid carcinomas.
AuthorsYuri E Demidchik, Vladimir A Saenko, Shunichi Yamashita
JournalArquivos brasileiros de endocrinologia e metabologia (Arq Bras Endocrinol Metabol) Vol. 51 Issue 5 Pg. 748-62 (Jul 2007) ISSN: 0004-2730 [Print] Brazil
PMID17891238 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Review)
Topics
  • Adolescent
  • Age Distribution
  • Carcinoma (epidemiology, genetics, pathology, therapy)
  • Chernobyl Nuclear Accident
  • Child
  • Child, Preschool
  • Europe, Eastern (epidemiology)
  • Female
  • Humans
  • Incidence
  • Infant
  • Infant, Newborn
  • Male
  • Neoplasms, Radiation-Induced (epidemiology, genetics, pathology, therapy)
  • Radioactive Hazard Release
  • Thyroid Neoplasms (epidemiology, genetics, pathology, therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: